Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Elderly patients with COPD require more health care than elderly heart failure patients do in a hospital-based home care setting.

Persson HL, Lyth J, Wiréhn AB, Lind L.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 16;14:1569-1581. doi: 10.2147/COPD.S207621. eCollection 2019.

2.

Can a telemonitoring system lead to decreased hospitalization in elderly patients?

Lyth J, Lind L, Persson HL, Wiréhn AB.

J Telemed Telecare. 2019 Jul 10:1357633X19858178. doi: 10.1177/1357633X19858178. [Epub ahead of print] No abstract available.

3.

The influence of disease severity and lifestyle factors on the peak annual 25(OH)D value of COPD patients.

Kentson M, Leanderson P, Jacobson P, Persson HL.

Int J Chron Obstruct Pulmon Dis. 2018 Apr 27;13:1389-1398. doi: 10.2147/COPD.S156121. eCollection 2018.

4.

Oxidant status, iron homeostasis, and carotenoid levels of COPD patients with advanced disease and LTOT.

Kentson M, Leanderson P, Jacobson P, Persson HL.

Eur Clin Respir J. 2018 Mar 9;5(1):1447221. doi: 10.1080/20018525.2018.1447221. eCollection 2018.

5.

Oxidant-induced autophagy and ferritin degradation contribute to epithelial-mesenchymal transition through lysosomal iron.

Sioutas A, Vainikka LK, Kentson M, Dam-Larsen S, Wennerström U, Jacobson P, Persson HL.

J Inflamm Res. 2017 Mar 28;10:29-39. doi: 10.2147/JIR.S128292. eCollection 2017.

6.

Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50-64 years, the SCAPIS Pilot Study.

Torén K, Bake B, Olin AC, Engström G, Blomberg A, Vikgren J, Hedner J, Brandberg J, Persson HL, Sköld CM, Rosengren A, Bergström G, Janson C.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 22;12:973-980. doi: 10.2147/COPD.S127336. eCollection 2017.

7.

A retrospective chart review of pirfenidone-treated patients in Sweden: the REPRIS study.

Sköld CM, Janson C, Elf ÅK, Fiaschi M, Wiklund K, Persson HL.

Eur Clin Respir J. 2016 Jul 18;3:32035. doi: 10.3402/ecrj.v3.32035. eCollection 2016.

8.

Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).

Torén K, Olin AC, Lindberg A, Vikgren J, Schiöler L, Brandberg J, Johnsson Å, Engström G, Persson HL, Sköld M, Hedner J, Lindberg E, Malinovschi A, Piitulainen E, Wollmer P, Rosengren A, Janson C, Blomberg A, Bergström G.

Int J Chron Obstruct Pulmon Dis. 2016 May 2;11:927-33. doi: 10.2147/COPD.S104644. eCollection 2016.

9.

Does quantitative lung SPECT detect lung abnormalities earlier than lung function tests? Results of a pilot study.

Norberg P, Persson HL, Schmekel B, Carlsson GA, Wahlin K, Sandborg M, Gustafsson A.

EJNMMI Res. 2014 Dec;4(1):39. doi: 10.1186/s13550-014-0039-1. Epub 2014 Aug 1.

10.

Medical talc pleurodesis: which patient with cancer benefits least?

Wajda A, Engström H, Persson HL.

J Palliat Med. 2014 Jul;17(7):822-8. doi: 10.1089/jpm.2013.0591. Epub 2014 Jun 2.

11.

Intriguing bronchoalveolar lavage proteome in a case of pulmonary langerhans cell histiocytosis.

Ghafouri B, Persson HL, Tagesson C.

Am J Case Rep. 2013 Apr 29;14:129-33. doi: 10.12659/AJCR.889037. Print 2013.

12.

Quantitative lung SPECT applied on simulated early COPD and humans with advanced COPD.

Norberg P, Persson HL, Carlsson GA, Bake B, Kentson M, Sandborg M, Gustafsson A.

EJNMMI Res. 2013 Apr 19;3(1):28. doi: 10.1186/2191-219X-3-28.

13.

Vitamin D enhances IL-1β secretion and restricts growth of Mycobacterium tuberculosis in macrophages from TB patients.

Eklund D, Persson HL, Larsson M, Welin A, Idh J, Paues J, Fransson SG, Stendahl O, Schön T, Lerm M.

Int J Mycobacteriol. 2013 Mar;2(1):18-25. doi: 10.1016/j.ijmyco.2012.11.001. Epub 2012 Dec 20.

14.

Increased Lysosomal Membrane Permeabilization in Oxidant-exposed Macrophages of Human Fibrotic Lungs.

Persson HL, Vainikka LK.

J Cell Death. 2013 Dec 9;6:69-74. doi: 10.4137/JCD.S13271. eCollection 2013.

15.

Leaky lysosomes in lung transplant macrophages: azithromycin prevents oxidative damage.

Persson HL, Vainikka LK, Sege M, Wennerström U, Dam-Larsen S, Persson J.

Respir Res. 2012 Sep 24;13:83. doi: 10.1186/1465-9921-13-83.

16.

TNF-α-stimulated macrophages protect A549 lung cells against iron and oxidation.

Persson HL, Vainikka LK, Eriksson I, Wennerström U.

Exp Toxicol Pathol. 2013 Jan;65(1-2):81-9. doi: 10.1016/j.etp.2011.06.004. Epub 2011 Jul 8.

PMID:
21741805
17.

Lane-Hamilton syndrome: ferritin protects lung macrophages against iron and oxidation.

Persson HL, Vainikka LK, Eriksson HB, Wennerström U.

Chest. 2011 Feb;139(2):361-367. doi: 10.1378/chest.10-0818. Epub 2010 Aug 12.

PMID:
20705801
18.

TNF-alpha preserves lysosomal stability in macrophages: a potential defense against oxidative lung injury.

Persson HL, Vainikka LK.

Toxicol Lett. 2010 Feb 1;192(2):261-7. doi: 10.1016/j.toxlet.2009.10.031. Epub 2009 Nov 10.

PMID:
19900513
19.

Lysosomal iron in pulmonary alveolar proteinosis: a case report.

Persson HL, Vainikka LK.

Eur Respir J. 2009 Mar;33(3):673-9. doi: 10.1183/09031936.00044108.

20.
21.

Iron-binding drugs targeted to lysosomes: a potential strategy to treat inflammatory lung disorders.

Persson HL, Richardson DR.

Expert Opin Investig Drugs. 2005 Aug;14(8):997-1008. Review.

PMID:
16050792
22.
23.

Molecular pharmacology of the interaction of anthracyclines with iron.

Xu X, Persson HL, Richardson DR.

Mol Pharmacol. 2005 Aug;68(2):261-71. Epub 2005 May 9. Review.

PMID:
15883202
24.

Radiation-induced cell death: importance of lysosomal destabilization.

Persson HL, Kurz T, Eaton JW, Brunk UT.

Biochem J. 2005 Aug 1;389(Pt 3):877-84.

25.

The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.

Yu Z, Eaton JW, Persson HL.

Redox Rep. 2003;8(6):347-55.

PMID:
14980067
26.

Prevention of oxidant-induced cell death by lysosomotropic iron chelators.

Persson HL, Yu Z, Tirosh O, Eaton JW, Brunk UT.

Free Radic Biol Med. 2003 May 15;34(10):1295-305.

PMID:
12726917
27.

Intralysosomal iron: a major determinant of oxidant-induced cell death.

Yu Z, Persson HL, Eaton JW, Brunk UT.

Free Radic Biol Med. 2003 May 15;34(10):1243-52.

PMID:
12726912
28.

Alpha-lipoic acid and alpha-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis.

Persson HL, Svensson AI, Brunk UT.

Redox Rep. 2001;6(5):327-34.

PMID:
11778851
29.

Supplemental Content

Loading ...
Support Center